Insider · CIK 0001598426

Aliski William

Reports to the SEC for 3 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001598426

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-10	XFORX4 Pharmaceuticals, IncA Award	Director	AAward	+45K sh	—	—	96,667
2023-06-13	XFORX4 Pharmaceuticals, IncA Award	Director	AAward	+45K sh	—	—	51,667
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPU Disposition from Tender	Director	UDisposition from Tender	−8,500 sh	—	—	0
2022-06-06	XFORX4 Pharmaceuticals, IncA Award	Director	AAward	+6,667 sh	—	—	6,667
2021-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2021-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,125 sh	—	—	4,125
2021-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+2,145 sh	—	—	66,849
2021-06-02	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	$9.50	+$57K	6,000
2021-02-23	RAREUltragenyx Pharmaceutical Inc.G Gift	Director	GGift	−1,000 sh	—	—	64,704
2021-02-19	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	0
2021-02-19	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−7,500 sh	$149.01	−$1.12M	65,704
2021-02-19	RAREUltragenyx Pharmaceutical Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$97.85	+$734K	73,204
2020-12-16	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-08-27	RAREUltragenyx Pharmaceutical Inc.G Gift	Director	GGift	−1,000 sh	—	—	65,704
2020-08-21	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2020-08-21	RAREUltragenyx Pharmaceutical Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$58.74	+$294K	62,018
2020-08-21	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−5,000 sh	$86.57	−$433K	57,018
2020-06-26	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+2,550 sh	—	—	57,018
2020-06-26	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,250 sh	—	—	4,250
2020-06-10	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+3,427 sh	—	—	3,427
2020-05-21	RAREUltragenyx Pharmaceutical Inc.G Gift	Director	GGift	−1,000 sh	—	—	65,704
2020-05-18	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	0
2020-05-18	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−7,500 sh	$74.65	−$560K	47,924
2020-05-18	RAREUltragenyx Pharmaceutical Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$40.37	+$303K	55,424
2020-05-18	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−20K sh	$74.02	−$1.48M	70,350
2019-12-04	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-09-18	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+6,854 sh	—	—	6,854
2019-06-11	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2019-06-11	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,000 sh	—	—	47,924
2018-12-14	APPLIED GENETIC TECHNOLOGIES CORPP Purchase	Director	PPurchase	+4,300 sh	$3.25	+$14K	8,000
2018-12-14	APPLIED GENETIC TECHNOLOGIES CORPP Purchase	Director	PPurchase	+500 sh	$3.24	+$1,620	8,500
2018-12-14	APPLIED GENETIC TECHNOLOGIES CORPP Purchase	Director	PPurchase	+1,200 sh	$3.23	+$3,882	3,700
2018-12-07	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−6,000 sh	$49.69	−$298K	90,350
2018-11-15	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-11-08	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−6,000 sh	$55.67	−$334K	96,350
2018-10-08	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−6,000 sh	$73.38	−$440K	102,350
2018-09-20	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-08-08	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−3,750 sh	$76.66	−$287K	72,610
2018-06-19	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,000 sh	—	—	76,360
2018-06-19	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2018-04-19	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−650 sh	$53.97	−$35.1K	108,350
2018-01-23	RAREUltragenyx Pharmaceutical Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.5K sh	$21.00	+$242K	73,360
2018-01-23	RAREUltragenyx Pharmaceutical Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.5K sh	—	—	0
2017-06-22	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+1,875 sh	—	—	61,860
2017-06-22	RAREUltragenyx Pharmaceutical Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+3,750 sh	—	—	3,750

Recent filings

Accepted (ET)
Jun 114
Aliski William0001628280-24-027677
SEC(opens sec.gov)
Jun 144
Aliski William0001628280-23-022099
SEC(opens sec.gov)
Dec 14
Aliski William0001062993-22-023027
SEC(opens sec.gov)
Jun 274
Aliski William0001628280-22-018048
SEC(opens sec.gov)
Dec 24
Aliski William0001062993-21-012049
SEC(opens sec.gov)
Jun 284
Aliski William0001209191-21-043547
SEC(opens sec.gov)
Jun 24
Aliski William0001628280-21-011546
SEC(opens sec.gov)
Feb 234
Aliski William0001209191-21-013100
SEC(opens sec.gov)
Feb 35
Aliski William0001209191-21-007553
SEC(opens sec.gov)
Dec 184
Aliski William0001273636-20-000009
SEC(opens sec.gov)

Companies

Address

C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT

NOVATO, CA, 94949